Cyproterone Acetate

CAS 427-51-0 9 current records 2 historicalSmall Molecule

Who holds supplier records for Cyproterone Acetate? 9 organisations hold a current record for Cyproterone Acetate: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 9 of them hold a valid EU Certificate of Suitability (10 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: Italy (2), China (2), Germany (1), India (1) and 2 other countries (2); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Cyproterone Acetate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/cyproterone-acetate

Reading the evidence

  • 9 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 6 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (9)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Cyproterone Acetate. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Cyproterone Acetate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (10)

Certificates of Suitability on the EDQM register for Cyproterone Acetate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 14 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. TaizhouCN
CEP 2026-308 - Rev 00
Cyproterone acetate, Process III
Jul 2026—
HUBEI GEDIAN HUMANWELL PHARMACEUTICAL CO., LTD. HuanggangCN
CEP 2025-414 - Rev 00
Cyproterone acetate, Micronised and non-micronised
Dec 2025—
TAPI NL B.V. AmsterdamNL
CEP 2000-046 - Rev 06
Cyproterone acetate
Aug 2025—
FARMABIOS S.p.A Gropello CairoliIT
CEP 2018-270 - Rev 01
Cyproterone acetate, Micronised
Apr 2025Inspected Jul 2026
Italy
CIPLA LIMITED MumbaiIN
CEP 2007-038 - Rev 04
Cyproterone acetate
Apr 2025—
NEWCHEM S.p.A. MilanoIT
R0-CEP 2020-365 - Rev 02
Cyproterone acetate, Micronised
Jul 2023—
HUBEI GEDIAN HUMANWELL PHARMACEUTICAL CO., LTD. E-ZhouCN
R1-CEP 2013-244 - Rev 01
Cyproterone acetate, Process A
Jan 2023—
JIANGSU GRAND XIANLE PHARMACEUTICAL CO., LTD. YanchengCN
R1-CEP 2007-317 - Rev 04
Cyproterone acetate
May 2022—
CURIA SPAIN S.A.U. BoecilloES
R1-CEP 2012-192 - Rev 01
Cyproterone acetate
Aug 2021—
BAYER AG LeverkusenDE
R1-CEP 1999-102 - Rev 04
Cyproterone acetate, Variant 1
Mar 2017—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (2)

Organisations whose Type II DMFs for Cyproterone Acetate are no longer active. These show a past filing, not current supply.

Show all 2 historical records
  • SICOR DE MEXICO SA DE CV
    Inactive DMF 14078 · filed Apr 1999
  • SCHERING AG
    Inactive DMF 677, 2043 · filed Feb 1973

Overview

Cyproterone Acetate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL139835).

Chemical identity

IUPAC name
[(1S,2S,3S,5R,11R,12S,15R,16S)-15-acetyl-9-chloro-2,16-dimethyl-6-oxo-15-pentacyclo[9.7.0.02,8.03,5.012,16]octadeca-7,9-dienyl] acetate
Canonical SMILES
CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)[C@@H]5C[C@@H]5[C@]34C)Cl)C)OC(=O)C
InChIKey
UWFYSQMTEOIJJG-FDTZYFLXSA-N
Synonyms
Androcur, Androcur 10, Ciproterona, Cyprostat, Cyproterone, Cyproterone 17.alpha.-acetate, Cyproterone acetate, Diane, NSC-81430, SH 714, SH-714, SH714

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Cyproterone Acetate?

9 organisations hold an active US FDA Type II Drug Master File or a CEP for Cyproterone Acetate: Farmabios S.p.A. (Italy), Bayer AG (Germany), Cipla Limited (India), CURIA SPAIN SAU (Spain), Hubei Gedian Humanwell Pharmaceutical Co. Ltd (China), JIANGSU GRAND XIANLE PHARMACEUTICAL CO LTD (China), NEWCHEM SPA (Italy) and TAPI NL BV (Netherlands), and 1 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Cyproterone Acetate Drug Master Files are active?

Farmabios S.p.A. (DMF 18043). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Cyproterone Acetate records mean?

2 organisations have only inactive Type II DMFs for Cyproterone Acetate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Cyproterone Acetate have a European Certificate of Suitability?

Yes. 9 organisations hold a valid CEP for Cyproterone Acetate on the EDQM register, including ZHEJIANG XIANJU PHARMACEUTICAL CO., LTD. Taizhou (CN), HUBEI GEDIAN HUMANWELL PHARMACEUTICAL CO., LTD. Huanggang (CN), TAPI NL B.V. Amsterdam (NL), FARMABIOS S.p.A Gropello Cairoli (IT), CIPLA LIMITED Mumbai (IN) and NEWCHEM S.p.A. Milano (IT) and 4 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Cyproterone Acetate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Cyproterone Acetate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.